In our last post we looked at how researchers at the Gender, Law and Drugs (GLaD) program at La Trobe University, Melbourne, have been running the Post-Cure Lives Project. This was designed to document the post-cure experiences of people successfully treated for hepatitis C,the views of key stakeholders,and latent and emerging discrimination-related challenges in a hepatitis C post-cure world.
Readers of this blog will know hepatitis C well as a blood-borne virus which can lead to cirrhosis, liver failure and other major health problems. Along with hepatitis B, it is the primary cause of liver cancer in Australia—the fastest growing cause of cancer death in the country.
“Hello…hello,” the woman called to me. “Do you work there?” she asked pointing to the Hepatitis SA office. I nodded.
“Can I talk to you, ask you something?” she continued. She needed to get back to the hospital where she worked; her lunch break was almost over, so we spoke as she walked. Shui* told her story and gave me her contact details.